In the present study, based on several well-known open databases and loss-of-function assays, we conducted a pan-cancer analysis to elaborate the PDIA5 profiles, including DNA methylation, genetic alterations, and its associations with immune infiltration and other signatures of interest in human cancers. Here, PDIA5 is linked to cancer.